Catch up on the most-well viewed radiology content in October 2026.
News|Slideshows|February 22, 2026
Radiology Roundup of New FDA Clearances and Approvals: February 15 — February 21
Author(s)Diagnostic Imaging Staff
Catch up on a variety of new FDA clearances and approvals in radiology from the past week.
Advertisement
From new 3T and 1.5T MRI devices to new preset features for a point-of-care ultrasound system and an expanded approval for a MRI contrast agent, here are key FDA clearances and approvals in radiology from the past week.
Advertisement
Related to this article
Catch up on a variety of FDA news in radiology from the past week.
Catch up on the top AI-related news and research in radiology over the past month.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on the most well-viewed radiology video interviews from Diagnostic Imaging in September 2026.
A Kaiser score > 5 with breast MRI demonstrated a 97 percent sensitivity and 87.9 percent specificity for predicting malignancy in patients with BI-RADS 0 or 4 presentations on mammography and breast ultrasound, according to a new study.
The NEXT-Cue AI software, which incorporates analysis of brain MRI scans, reportedly facilitates prognostic assessments of potential progression from mild cognitive impairment (MCI) to Alzheimer’s disease within five years.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging's Weekly Scan: October 25 — October 31
2
FDA Clears CTA-Based AI Software for Enhanced Visualization of Head and Neck Arteries
3
Key Features with EPNI on CT May More than Double Mortality Risk in Pancreatic Cancer
4
Top Five Radiology Video Interviews in October 2026
5